Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

Item

http://www.wikidata.org/entity/Q42662183

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

@en

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

@nl

type

Item

label

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

@en

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

@nl

prefLabel

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

@en

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

@nl

P1476

Flow cytometry immunophenotyping for diagnosis of myelodysplastic syndrome.

@en

P2093

Mario Cazzola

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

The World Health Organization (WHO) classification of the myeloid neoplasms

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

Mutation in TET2 in myeloid cancers

Acquired mutations in TET2 are common in myelodysplastic syndromes.

Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome.

Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach.

Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study.

Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.

P304

1041-1043

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3324/HAEMATOL.2009.007682

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26706779

http://www.w3.org/2001/XMLSchema#string

P698

19644135

http://www.w3.org/2001/XMLSchema#string

P932

2719025

http://www.w3.org/2001/XMLSchema#string